{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:20:04Z","timestamp":1790983204794,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jad.2008.07.014","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T14:54:17Z","timestamp":1220540057000},"page":"14-31","source":"Crossref","is-referenced-by-count":134,"title":["Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: A systematic review"],"prefix":"10.1016","volume":"114","author":[{"given":"Alexander","family":"Konnopka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Leichsenring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leibing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Helmut","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jad.2008.07.014_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1468-1331.2005.01196.x","article-title":"Cost of anxiety disorders in Europe","volume":"12","author":"Andlin-Sobocki","year":"2005","journal-title":"Eur. J. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2008.07.014_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2005.01202.x","article-title":"Cost of disorders of the brain in Europe","volume":"12","author":"Andlin-Sobocki","year":"2005","journal-title":"Eur. J. Neurol."},{"issue":"19","key":"10.1016\/j.jad.2008.07.014_bib43","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial","volume":"283","author":"Barlow","year":"2006","journal-title":"JAMA"},{"issue":"1\u20133","key":"10.1016\/j.jad.2008.07.014_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2007.03.013","article-title":"Economic costs of full-blown and subthreshold panic disorder","volume":"104","author":"Batelaan","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2008.07.014_bib4","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.jad.2008.07.014_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L","article-title":"Economic costs of anxiety disorders","volume":"2","author":"DuPont","year":"1996","journal-title":"Anxiety"},{"key":"10.1016\/j.jad.2008.07.014_bib6","article-title":"The economic and social costs of panic disorder","volume":"38","author":"Edlund","year":"1987","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00043764-200301000-00007","article-title":"The health and productivity cost burden of the \u201ctop 10\u201d physical and mental health conditions affecting six large U.S. employers in 1999","volume":"45","author":"Goetzel","year":"2003","journal-title":"J. Occup. Environ. Med."},{"issue":"11","key":"10.1016\/j.jad.2008.07.014_bib45","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1176\/ajp.156.11.1819","article-title":"Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991\u20131996","volume":"156","author":"Goisman","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4088\/JCP.v60n0702","article-title":"The economic burden of anxiety disorders in the 1990s","volume":"60","author":"Greenberg","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2008.07.014_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10198-004-0272-z","article-title":"Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom","volume":"6","author":"Guest","year":"2005","journal-title":"Eur. J. Health. Econ."},{"key":"10.1016\/j.jad.2008.07.014_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/j.1440-1614.2004.01423.x","article-title":"Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder","volume":"38","author":"Heuzenroeder","year":"2004","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S003329170300881X","article-title":"Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders","volume":"34","author":"Issakidis","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2008.07.014_bib12","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1345\/aph.1H156","article-title":"Cost-effectiveness analysis of escitalopram compared with paroxetine in treatment of generalized anxiety disorder in the United Kingdom","volume":"40","author":"Jorgensen","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jad.2008.07.014_bib13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archpsyc.59.12.1098","article-title":"Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder","volume":"59","author":"Katon","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S0033291705006896","article-title":"Incremental cost-effectiveness of a collaborative care intervention for panic disorder","volume":"36","author":"Katon","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2008.07.014_bib15","first-page":"95","article-title":"Reducing the number of emergency department visits and costs associated with anxiety: a randomized controlled study","volume":"13","author":"Kolbasovsky","year":"2007","journal-title":"Am. J. Manag. Care."},{"issue":"1","key":"10.1016\/j.jad.2008.07.014_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000162299","article-title":"The Social Phobia Research Network","volume":"78","author":"Leichsenring","year":"2009","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.jad.2008.07.014_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0163-8343(96)00154-5","article-title":"Service utilization and expenditures for the treatment of panic disorder","volume":"19","author":"Leon","year":"1997","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00019053-200018010-00003","article-title":"Social phobia. Epidemiology and cost of illness","volume":"18","author":"Lipsitz","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"Suppl 1","key":"10.1016\/j.jad.2008.07.014_bib19","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/s10198-005-0284-3","article-title":"Economic evidence in anxiety disorders: a review","volume":"5","author":"Lothgren","year":"2004","journal-title":"Eur. J. Health. Econ."},{"key":"10.1016\/j.jad.2008.07.014_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/da.10131","article-title":"Medical and productivity costs of anxiety disorders: case control study","volume":"19","author":"Marciniak","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jad.2008.07.014_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/da.20074","article-title":"The cost of treating anxiety: the medical and demographic correlates that impact total medical costs","volume":"21","author":"Marciniak","year":"2005","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jad.2008.07.014_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00019053-200018040-00006","article-title":"Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder","volume":"18","author":"Mavissakalian","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jad.2008.07.014_bib23","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4088\/JCP.v68n0710","article-title":"Cost-efficacy of individual and combined treatments for panic disorder","volume":"68","author":"McHugh","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.4088\/JCP.v67n0803","article-title":"Overlap of anxiety and depression in a managed care population: prevalence and association with resource utilization","volume":"67","author":"McLaughlin","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2005.05.003","article-title":"A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia","volume":"88","author":"Mitte","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2008.07.014_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1037\/0033-2909.131.5.785","article-title":"Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy","volume":"131","author":"Mitte","year":"2005","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2008.07.014_bib27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cpr.2007.01.015","article-title":"Quality of life in the anxiety disorders: a meta-analytic review","volume":"27","author":"Olatunji","year":"2007","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2008.07.014_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.genhosppsych.2007.04.004","article-title":"Generalized anxiety disorder, somatic pain and health care costs","volume":"29","author":"Olfson","year":"2007","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib29","series-title":"Health Data 2007, Statistics and Indicators for 30 Countries","author":"Organisation for Economic Cooperation and Development\u2014OECD","year":"2007"},{"key":"10.1016\/j.jad.2008.07.014_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1037\/0022-006X.68.4.556","article-title":"Empirically supported treatments for panic disorder: costs, benefits, and stepped care","volume":"68","author":"Otto","year":"2000","journal-title":"J. Consult Clin. Psychol."},{"key":"10.1016\/j.jad.2008.07.014_bib31","first-page":"S370","article-title":"Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders","volume":"11","author":"Panzer","year":"2005","journal-title":"Am. J. Manag. Care."},{"key":"10.1016\/j.jad.2008.07.014_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00323-2","article-title":"The economic consequences of social phobia","volume":"68","author":"Patel","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jad.2008.07.014_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0887-6185(98)00026-7","article-title":"Medical utilisation and costs in panic disorder: a comparison with social phobia","volume":"12","author":"Rees","year":"1998","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jad.2008.07.014_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/16506070510008443","article-title":"Healthcare utilization following cognitive\u2013behavioral treatment for panic disorder with agoraphobia","volume":"34","author":"Roberge","year":"2005","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jad.2008.07.014_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0145445507309025","article-title":"Cognitive\u2013behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis","volume":"32","author":"Roberge","year":"2008","journal-title":"Behav. Modif."},{"key":"10.1016\/j.jad.2008.07.014_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/S0007125000293367","article-title":"Costs and offset effect in panic disorders","author":"Salvador-Carulla","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2008.07.014_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0887-6185(90)90012-X","article-title":"Economic and life consequences experienced by a group of individuals with panic disorder","volume":"4","author":"Siegel","year":"1990","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jad.2008.07.014_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1176\/appi.ps.53.6.714","article-title":"Quality of life in social anxiety disorder compared with panic disorder and the general population","volume":"53","author":"Simon","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2008.07.014_bib39","first-page":"193","article-title":"Costs of nine common mental disorders: implications for curative and preventive psychiatry","volume":"9","author":"Smit","year":"2006","journal-title":"J. Ment. Health Policy Econ."},{"key":"10.1016\/j.jad.2008.07.014_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/070674370605100206","article-title":"Prevalence and incidence studies of anxiety disorders: a systematic review of the literature","volume":"51","author":"Somers","year":"2006","journal-title":"Can. J. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.jad.2008.07.014_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-3999(94)90145-7","article-title":"Cost of anxiety disorders: impact of comorbidity","volume":"38","author":"Souetre","year":"1994","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2008.07.014_bib42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1176\/appi.ps.57.5.673","article-title":"Antidepressant adherence and medical resource use among managed care patients with anxiety disorders","volume":"57","author":"Stein","year":"2006","journal-title":"Psychiatr. Serv."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032708003133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032708003133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T21:13:09Z","timestamp":1684530789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032708003133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0165032708003133"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2008.07.014","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}